To our knowledge, this study firstly and comprehensively investigated the associations between SIRPG expression with tumor immune microenvironment phenotypes, its functional role in shaping T cell mediated-adaptive antitumor immunity, as well as its predictive value for PD-1 blockade in various cancers. The gene discussed is PDCD1; the disease is cancer.